Correlation Between Clal Biotechnology and Global Knafaim

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Global Knafaim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Global Knafaim into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Global Knafaim Leasing, you can compare the effects of market volatilities on Clal Biotechnology and Global Knafaim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Global Knafaim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Global Knafaim.

Diversification Opportunities for Clal Biotechnology and Global Knafaim

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Clal and Global is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Global Knafaim Leasing in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Global Knafaim Leasing and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Global Knafaim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Global Knafaim Leasing has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Global Knafaim go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Global Knafaim

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to under-perform the Global Knafaim. In addition to that, Clal Biotechnology is 1.88 times more volatile than Global Knafaim Leasing. It trades about -0.01 of its total potential returns per unit of risk. Global Knafaim Leasing is currently generating about 0.04 per unit of volatility. If you would invest  5,372  in Global Knafaim Leasing on August 27, 2024 and sell it today you would earn a total of  1,848  from holding Global Knafaim Leasing or generate 34.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  Global Knafaim Leasing

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's forward indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Global Knafaim Leasing 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Global Knafaim Leasing are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, Global Knafaim sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology and Global Knafaim Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and Global Knafaim

The main advantage of trading using opposite Clal Biotechnology and Global Knafaim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Global Knafaim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Global Knafaim will offset losses from the drop in Global Knafaim's long position.
The idea behind Clal Biotechnology Industries and Global Knafaim Leasing pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets